Skip to content
value.today

ArTara Therapeutics, Inc.

🇺🇸 New York, New York, USAPharmaceuticalsFounded 2017
Total raised
$4 M
1 round on record
Latest round
$4 M
Dec 2017
First round on record
Dec 2017
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of ArTara Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2017$4 MNo. 1$2 to $10 million

ArTara Therapeutics, Inc.: Raise no. 1, Dec 2017

Investors in this round

2 investors had bought by the notice of Jan 9, 2018: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M (amount offered: indefinite)
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Smith · Executive Officer
  • Jesse Shefferman · Executive Officer, Director
  • Randall Marshall · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David S. Smith, Secretary. Newest notice filed Jan 9, 2018. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • ArTara Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2018).

    SEC Form D · Jan 2018

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jan 2018

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of ArTara Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by ArTara Therapeutics, Inc.
NameRoleNamed in
David SmithExecutive officerJan 2018
Jesse SheffermanExecutive officerJan 2018
Randall MarshallExecutive officerJan 2018
Jesse SheffermanDirectorJan 2018
Randall MarshallDirectorJan 2018